LOS ANGELES, CA -(Marketwired – Nov 25, 2013) – The subsidiary of SK3 Group, Inc. (OTC Pink: SKTO) Medical Greens broadcasts its new product, T-Hydrocan™, a brand new line of medicinal hashish merchandise. Whereas the main target of SK3's Berkeley Bio efforts lies in growing potential most cancers therapies utilizing non-psychoactive parts of the hashish/hemp plant, as mirrored within the lately introduced Dharmanol™ product line, many sufferers have discovered appreciable profit from oral administration. of THC, the psychoactive ingredient discovered within the hashish/hemp plant, when used to deal with all kinds of medical situations.
An artificial model of THC, Marinol™ has been accessible by prescription for a few years, and is prescribed to alleviate ache and nausea from most cancers and the unintended effects of radiation and chemotherapy. Curiously, Marinol™ is usually prescribed to most cancers sufferers, and people who even have entry to pure cannabis-like merchandise a lot want pure merchandise to artificial prescribed drugs.
T-Hydrocan™ tablets include the psychoactive ingredient THC, in addition to the total vary of cannabinoids which are naturally current within the hashish/hemp plant. Along with cannabinoids, T-Hydrocan™ tablets include a steam-distilled extract of hashish/hemp, which incorporates pure terpenes and terpenoids that work synergistically with cannabinoids.
Totally different variations of T-Hydrocan™ shall be provided, adjusting the fundamental T-Hydrocan™ system for various functions. T-Hydrocan™ Complete-Plant™ incorporates psychoactive, decarboxylated THC, in addition to all the vary of associated medicinal parts discovered within the hashish/hemp plant. T-Hydrocan™ Citrolene™ incorporates a wholesome dose of the terpene d-Limonene, which attaches to the identical receptors as tranquilizers equivalent to Valium and Xanax, including a pure enjoyable ingredient to the drugs. T-Hydrocan – CBD™ provides an quantity of CBD equal to THC.
The T-Hydrocan ™ line of cannabis-based medicines shall be accessible by way of dispensaries and collectives which have partnered with Medical Greens' wholesale managed collectives.
“We’re happy so as to add this new product to the arsenal of merchandise accessible by way of Medical Greens to battle most cancers and stay up for including many extra,” stated President Artemus Mayor. “We anticipate this product to contribute considerably to the Firm's development because it responds to this underserved market.”
FDA assertion
The statements on this doc haven’t been evaluated or authorized by the FDA. The merchandise and statements referred to on this doc aren’t meant to diagnose, deal with, remedy or stop any illness.
About SK3
SK3 is a healthcare logistics and achievement consultancy targeted on the supply of other care and drugs. With skilled administration, modern know-how and greatest practices, SK3 brings standardization and transparency to this quickly rising phase of the choice care discipline.
Protected Harbor Assertion
This press launch incorporates forward-looking statements inside the that means of Part 27A of the Securities Act of 1933 and Part 21E of the Securities Change Act of 1934. These forward-looking statements are primarily based on administration's present plans and expectations and are topic to a lot of uncertainties and dangers that would considerably have an effect on the corporate's present plans and expectations, in addition to future outcomes of operations and monetary situation. A extra intensive checklist of dangers and components which will have an effect on the corporate's enterprise prospects and trigger precise outcomes to vary materially from these described within the forward-looking statements will be discovered within the experiences and different paperwork submitted by the corporate with the Securities and Change Fee. . The corporate undertakes no obligation to publicly replace or revise any forward-looking statements, whether or not on account of new info, future occasions or in any other case.
